Clinical Trial Update: Imetelstat Combinations in Relapsed AML [Phase 1]

View source ↗

Summary

Clinical trial update notes a Phase 1 study of imetelstat in combination regimens for relapsed acute myeloid leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: Douglas Tremblay | Conditions: Relapsed Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING